MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer

類似資料

• Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
  著者:: Bains, Simer J., 等
  出版事項: (2019)
• High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
  著者:: Abrahamsson, Hanna, 等
  出版事項: (2019)
• Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer
  著者:: Hektoen, Helga Helseth, 等
  出版事項: (2015)
• Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
  著者:: Kalanxhi, Erta, 等
  出版事項: (2018)
• Personalized radiotherapy: concepts, biomarkers and trial design
  著者:: Ree, A H, 等
  出版事項: (2015)